Technical Analysis for HRMY - Harmony Biosciences Holdings, Inc.

Grade Last Price % Change Price Change
grade D 33.6 -2.67% -0.92
HRMY closed down 2.67 percent on Friday, September 18, 2020, on 1.16 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical HRMY trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Hot IPO Pullback Bullish Swing Setup -2.67%
Outside Day Range Expansion -2.67%
Hot IPO Pullback Bullish Swing Setup -7.89%
NR7 Range Contraction -7.89%
Inside Day Range Contraction -7.89%
Hot IPO Pullback Bullish Swing Setup -5.62%
Older End-of-Day Gignals for HRMY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 22 hours ago
Down 2 % about 22 hours ago
Down 1% about 22 hours ago
Fell Below Previous Day's Low about 22 hours ago
60 Minute Opening Range Breakdown about 22 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.
Chemistry Pharmaceutical Chloroarenes Ethers Piperidines Narcolepsy Stimulants Rare Neurological Disorders

Is HRMY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 47.37
52 Week Low 31.88
Average Volume 266,452
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 37.72
10-Day Moving Average 39.03
Average True Range 3.93
ADX 0.0
+DI 20.01
-DI 20.89
Chandelier Exit (Long, 3 ATRs ) 35.58
Chandelier Exit (Short, 3 ATRs ) 43.67
Upper Bollinger Band 45.03
Lower Bollinger Band 30.41
Percent B (%b) 0.22
BandWidth 38.76
MACD Line -0.20
MACD Signal Line 0.59
MACD Histogram -0.7928
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 38.90
Resistance 3 (R3) 39.29 37.91 38.01
Resistance 2 (R2) 37.91 36.56 37.72 37.72
Resistance 1 (R1) 35.76 35.73 35.07 35.37 37.42
Pivot Point 34.38 34.38 34.04 34.19 34.38
Support 1 (S1) 32.23 33.03 31.54 31.84 29.78
Support 2 (S2) 30.85 32.20 30.66 29.48
Support 3 (S3) 28.70 30.85 29.19
Support 4 (S4) 28.31